REPL logo

Replimune (REPL) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$74.46 M
-$72.13 M-49.21%

March 31, 2024


Summary


Performance

REPL Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherREPLbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$113.49 M
-$38.16 M-25.16%

September 30, 2024


Summary


Performance

REPL Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherREPLbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

REPL Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-49.2%+52.4%
3 y3 years-59.2%-29.1%
5 y5 years+189.7%+112.9%

REPL Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-59.2%at low-45.1%+52.4%
5 y5-year-59.2%+189.7%-65.0%+161.9%
alltimeall time-59.2%+323.5%-65.0%+779.1%

Replimune Cash And Cash Equivalents History

DateAnnualQuarterly
Sep 2024
-
$113.49 M(-25.2%)
Jun 2024
-
$151.66 M(+103.7%)
Mar 2024
$74.46 M(-49.2%)
$74.46 M(-23.8%)
Dec 2023
-
$97.67 M(+28.5%)
Sep 2023
-
$76.00 M(-28.6%)
Jun 2023
-
$106.48 M(-27.4%)
Mar 2023
$146.59 M(+38.4%)
$146.59 M(-29.1%)
Dec 2022
-
$206.67 M(+132.4%)
Sep 2022
-
$88.93 M(-20.8%)
Jun 2022
-
$112.25 M(+5.9%)
Mar 2022
$105.95 M(-42.0%)
$105.95 M(-19.9%)
Dec 2021
-
$132.28 M(-17.3%)
Sep 2021
-
$159.97 M(-16.9%)
Jun 2021
-
$192.53 M(+5.5%)
DateAnnualQuarterly
Mar 2021
$182.52 M(+206.8%)
$182.52 M(-43.7%)
Dec 2020
-
$324.48 M(+648.9%)
Sep 2020
-
$43.33 M(-58.7%)
Jun 2020
-
$104.80 M(+76.1%)
Mar 2020
$59.50 M(+131.5%)
$59.50 M(-5.6%)
Dec 2019
-
$63.00 M(+18.2%)
Sep 2019
-
$53.30 M(+38.9%)
Jun 2019
-
$38.36 M(+49.3%)
Mar 2019
$25.70 M(+46.2%)
$25.70 M(+22.1%)
Dec 2018
-
$21.05 M(-9.6%)
Sep 2018
-
$23.28 M(+80.3%)
Jun 2018
-
$12.91 M(-26.6%)
Mar 2018
$17.58 M(-14.6%)
$17.58 M
Mar 2017
$20.59 M
-

FAQ

  • What is Replimune annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Replimune?
  • What is Replimune annual cash & cash equivalents year-on-year change?
  • What is Replimune quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Replimune?
  • What is Replimune quarterly cash and cash equivalents year-on-year change?

What is Replimune annual cash & cash equivalents?

The current annual cash & cash equivalents of REPL is $74.46 M

What is the all time high annual cash & cash equivalents for Replimune?

Replimune all-time high annual cash & cash equivalents is $182.52 M

What is Replimune annual cash & cash equivalents year-on-year change?

Over the past year, REPL annual cash & cash equivalents has changed by -$72.13 M (-49.21%)

What is Replimune quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of REPL is $113.49 M

What is the all time high quarterly cash and cash equivalents for Replimune?

Replimune all-time high quarterly cash and cash equivalents is $324.48 M

What is Replimune quarterly cash and cash equivalents year-on-year change?

Over the past year, REPL quarterly cash and cash equivalents has changed by +$39.04 M (+52.43%)